A study involving 379 individuals who abstained from caffeine for 16 hours has revealed little variance in levels of alertness after receiving caffeine. Those who were medium/high caffeine consumers reported a decrease in alertness and an increase in headache if given the placebo, neither of which were reported by those who received caffeine. However, their post-caffeine levels of alertness were no higher than the non/low consumers who received a placebo, suggesting caffeine only brings coffee drinkers back up to 'normal'.
Latest Research News
A number of studies have shown the benefits of sleep for consolidating motor learning. A new study extends this research to a more complex motor task: "Guitar Hero III", a popular video game. There was significantly greater improvement after a night’s sleep (average 68% in performance accuracy vs 63% for students who learnt the task in the morning and were tested in the evening), and a significant correlation between sleep duration and the amount of improvement.
The role of the catechol-O-methyltransferase (COMT) gene in cognitive function has been the subject of some debate. The gene, which affects dopamine, comes in two flavors: Val and Met. One recent study found no difference between healthy carriers of these two gene variants in terms of cognitive performance, but did find differences in terms of neural activity. Another found that, although the gene did not affect Alzheimer’s risk in its own, it acted synergistically with the Alzheimer’s gene variant to do so.
A study involving 236 persons with multiple sclerosis has found that only 7% of those with secondary-progressive MS showed sufficient vitamin D in their blood, compared to 18.3% of patients with the less severe relapsing-remitting type, and that higher levels of vitamin D3 and its byproducts were associated with better scores on cognitive tests (especially reasoning and planning), and less brain atrophy and fewer brain lesions. Lower-than-normal vitamin D status is known to be associated with a higher risk of developing MS
Previous research has found that unexplained weight loss is an early sign of Alzheimer's. Now a study involving 140 older adults (60+), of whom half had early-stage Alzheimer's disease, has revealed that it is not the overall weight or fat levels that are important, but the loss of lean mass (weight of an individual's bones, muscles and organs without body fat). This directly correlated with reductions in the volume of the whole brain and of white matter only, along with declines in cognitive performance.
A study involving five patients with severe amnesia due to damage in the hippocampus, resulting in a condition comparable to Alzheimer's, has found that memory tests given 5-10 minutes after sad and happy film clips showed little (if any) memory of the details, but the generated emotion lasted for 20 to 30 minutes afterward. Interestingly, normal controls also felt happy for about the same length of time, but the impact of sad scenes was shorter. The findings challenge the idea that by minimizing a specific memory of past trauma, associated sadness will also decrease.
The largest ever trial of fish oil supplements has found no evidence that they offer benefits for cognitive function in older people. The British study enrolled 867 participants aged 70-80 years, and lasted two years. After two years, those receiving fish oil capsules had significantly higher levels of omega-3 fatty acids in their blood than those receiving placebo capsules. However, cognitive function did not decline in either group over the period. The researchers caution that it may be that more time is needed for benefits to show.
The Phase II clinical trial of a treatment using naturally occurring antibodies (IGIV) has achieved significantly lower rates of ventricular enlargement (6.7% vs 12.7% per year) and less whole-brain atrophy (1.6% vs 2.2% per year) than control subjects who initially received placebo. The trial ran for 18 months and involved 24 patients with mild to moderate Alzheimer's disease, of whom 16 received IGIV once or twice a month for the whole period, and 8 received a placebo for the first 6 months.
An intriguing set of experiments showing how you can improve perception by manipulating mindset found significantly improved vision when:
As we all know, being interrupted during a task greatly increases the chance we’ll go off-kilter (I discuss the worst circumstances and how you can minimize the risk of mistakes in my book Planning to remember). Medication errors occur as often as once per patient per day in some settings, and around one-third of harmful medication errors are thought to occur during medication administration.